Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of fluorinated active pharmaceutical ingredients (APIs) where the bromomethyl group enables further functionalization through cross-coupling reactions. Its electron-withdrawing trifluoromethyl and fluoro substituents enhance metabolic stability in drug candidates. Commonly employed in the preparation of kinase inhibitors and anti-inflammatory agents. Also utilized in agrochemical synthesis for building complex aromatic structures with improved bioavailability and target selectivity.